Literature DB >> 11442324

Clinical characteristics and management of ALS.

G D Borasio1, R G Miller.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common form of degenerative motor neuron disease in adulthood. The clinical picture was accurately described by Charcot over 125 years ago and consists of generalized fasciculations, progressive atrophy and weakness of the skeletal muscles, spasticity and pyramidal tract signs, dysarthria, dysphagia, and dyspnea. Pseudobulbar affect is common. Disease-specific treatment options are still unsatisfactory. However, therapeutic nihilism is not justified as a large array of palliative measures is available to enhance the quality of life of patients and their families. Palliative care in ALS is a multidisciplinary effort requiring careful coordination. An open and frank disclosure of the diagnosis is of paramount importance. Nutritional deficiency due to pronounced dysphagia can be relieved by a percutaneous endoscopic gastrostomy. Respiratory insufficiency can be effectively treated by noninvasive home mechanical ventilation. The terminal phase of the disease should be discussed, at the latest, when symptoms of dyspnea appear in order to prevent unwarranted fears of "choking to death." Collaboration with hospice and completion of advance directives can be of invaluable help in the terminal phase.

Entities:  

Mesh:

Year:  2001        PMID: 11442324     DOI: 10.1055/s-2001-15268

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  13 in total

Review 1.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

2.  Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.

Authors:  Andrea M Vincent; Eva L Feldman; Debbie K Song; Verena Jung; Andreas Schild; Wei Zhang; Michael J Imperiale; Nicholas M Boulis
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 4.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 5.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

Review 6.  Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.

Authors:  J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

7.  Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.

Authors:  Yvonne L Eaglehouse; Evelyn O Talbott; Yuefang Chang; Lewis H Kuller
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

Review 8.  Translational stem cell therapy for amyotrophic lateral sclerosis.

Authors:  Nicholas M Boulis; Thais Federici; Jonathan D Glass; J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-12-13       Impact factor: 42.937

Review 9.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

10.  Pain in amyotrophic lateral sclerosis: a neglected aspect of disease.

Authors:  Chalonda R Handy; Christina Krudy; Nicholas Boulis; Thais Federici
Journal:  Neurol Res Int       Date:  2011-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.